While Oregon Health & Science had its “AA-” credit rating affirmed, the outlook was revised to negative.
The two-hospital system had operating revenue of $3.3 billion for the nine months ending March 31, S&P said in the report.
While the system has “financial flexibility,” it also has what S&P described as an “ambitious capital strategy.” Oregon Health & Science is building a new 14-story patient tower in Portland.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
